Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

1.6K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Days at Home Among Children by Medical Complexity, Public/Private Insurance, and Urban/Rural Residence.

Academic pediatrics·2026
Same author

System dynamics modeling in support of community-based decision-making to reduce opioid overdose fatalities.

Frontiers in public health·2025
Same author

System dynamics modeling to inform implementation of evidence-based prevention of opioid overdose and fatality: A state-level model from the New York HEALing Communities Study.

The International journal on drug policy·2025
Same author

How can the United States make a great stride toward multiracial well-being?

PloS one·2025
Same author

Assessing policies to reduce adolescent overweight and obesity: Insights from a system dynamics model using data from the Health Behavior in School-Aged Children study.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2022
Same author

Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis.

Science advances·2022

Related Experiment Video

Updated: Apr 29, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

14.2K

Using simulation to compare 4 categories of intervention for reducing cardiovascular disease risks.

Gary Hirsch1, Jack Homer, Justin Trogdon

  • 1Gary Hirsch is an independent consultant based in Wayland, MA. Jack Homer is with Homer Consulting, Voorhees, NJ. At the time of the study, Justin Trogdon was with RTI International, Research Triangle Park, NC. Kristina Wile is with Systems Thinking Collaborative, Stow, MA. Diane Orenstein is with the Centers for Disease Control and Prevention (CDC), Atlanta, GA.

American Journal of Public Health
|May 17, 2014
PubMed
Summary

Implementing taxes and regulations is most effective for reducing cardiovascular disease costs and deaths long-term. Combining all interventions is necessary to improve outcomes in disadvantaged areas.

More Related Videos

Visualization of Intensity Levels to Reduce the Gap Between Self-Reported and Directly Measured Physical Activity
05:59

Visualization of Intensity Levels to Reduce the Gap Between Self-Reported and Directly Measured Physical Activity

Published on: March 7, 2019

8.2K
Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

6.8K

Related Experiment Videos

Last Updated: Apr 29, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

14.2K
Visualization of Intensity Levels to Reduce the Gap Between Self-Reported and Directly Measured Physical Activity
05:59

Visualization of Intensity Levels to Reduce the Gap Between Self-Reported and Directly Measured Physical Activity

Published on: March 7, 2019

8.2K
Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

6.8K

Area of Science:

  • Public Health
  • Health Economics
  • Preventive Medicine

Background:

  • Cardiovascular disease (CVD) poses a significant public health burden.
  • Effective interventions are needed to reduce CVD risk and associated costs.
  • Disparities exist in CVD outcomes, particularly in less-advantaged populations.

Purpose of the Study:

  • To project the multiyear impacts of various interventions on CVD risk.
  • To compare the effectiveness of different intervention categories.
  • To assess the potential for interventions to reduce health disparities.

Main Methods:

  • Utilized the Prevention Impacts Simulation Model (PRISM).
  • Simulated 22 interventions across 4 categories: clinical, behavioral support, health promotion and access, and taxes and regulation.
  • Compared impacts on costs and deaths for the US overall and a high-death-rate, less-advantaged county.

Main Results:

  • Taxes and regulation interventions demonstrated the greatest cost reductions (short- and long-term) and long-term death reductions.
  • Clinical interventions were most effective for short-term death reduction.
  • Achieving national-level cost and death rates in the less-advantaged county required a combination of all 4 intervention categories.

Conclusions:

  • Policy interventions, specifically taxes and regulations, show substantial promise for mitigating CVD burden.
  • A comprehensive, multi-category approach is essential for addressing health disparities in CVD.
  • Simulation modeling provides valuable insights for public health policy and resource allocation.